- Live market news
- Stocks
- UNCY
Unicycive Therapeutics Inc
UNCYStockUSA
Latest news on UNCYranked by Oyticker for market impact
- 72Impact
Unicycive resubmits NDA for oxylanthanum carbonate phosphate binder
Unicycive Therapeutics resubmitted its NDA for oxylanthanum carbonate (OLC), an oral phosphate binder for hyperphosphatemia in dialysis patients with CKD, with expected FDA acceptance within 30 days and PDUFA decision targeted six months thereafter.
UNCYBiotechnologyPharmaceuticalsHealthcare - 55Impact
UNCY litigation risk: manufacturing facility inspection allegations
Robbins LLP is investigating allegations that Unicycive Therapeutics failed to properly inspect a third-party vendor's manufacturing facility, creating potential shareholder recovery claims.
UNCYBiotechnologyPharmaceuticals
SEC filings
All its filingsWhat UNCY filed
- 29 Sept 2026
- 28 Sept 2026
- 12 Aug 2026
- 12 Aug 2026
- 2 Jul 2026
- 22 Jun 2026
- 5 Jun 2026
- 12 May 2026
- 12 May 2026
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.